Delivery of a Cancer-Testis Antigen-Derived Peptide Using Conformationally Restricted Dipeptide-Based Self-Assembled Nanotubes

2021 ◽  
Vol 18 (10) ◽  
pp. 3832-3842
Author(s):  
Priyanka Verma ◽  
Saikat Biswas ◽  
Nitin Yadav ◽  
Anjali Khatri ◽  
Hamda Siddiqui ◽  
...  
Keyword(s):  
Cancer Testis Antigen ◽  
Conformationally Restricted ◽  
Self Assembled ◽  
Cancer Testis

Cancer-testis antigen expression is shared between epithelial ovarian cancer tumors

2014 ◽  
Vol 133 ◽  
pp. 95
Author(s):  
A.E. Garcia-Soto ◽  
J.A. Lucci ◽  
E. Podack ◽  
T. Schreiber ◽  
E.D. Schroeder
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Antigen Expression ◽  
Cancer Testis Antigen ◽  
Cancer Testis

16. Cancer testis antigen (CTAg) expression is commonly observed in early-stage triple negative (TN) breast cancer

Pathology ◽  
2012 ◽  
Vol 44 ◽  
pp. S109
Author(s):  
S. Deb ◽  
F.J. Chionh ◽  
A. Chakrabarti ◽  
J. Seah ◽  
J.S. Cebon ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative ◽  
Early Stage ◽  
Cancer Testis Antigen ◽  
Cancer Testis

scholarly journals Cancer–testis antigen expression in triple-negative breast cancer

2011 ◽  
Vol 22 (1) ◽  
pp. 98-103 ◽  
Author(s):  
G. Curigliano ◽  
G. Viale ◽  
M. Ghioni ◽  
A.A. Jungbluth ◽  
V. Bagnardi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Antigen Expression ◽  
Cancer Testis Antigen ◽  
Cancer Testis

scholarly journals Transcription Factor BORIS (Brother of the Regulator of Imprinted Sites) Directly Induces Expression of a Cancer-Testis Antigen, TSP50, through Regulated Binding of BORIS to the Promoter

2011 ◽  
Vol 286 (31) ◽  
pp. 27378-27388 ◽  
Author(s):  
Natsuki Kosaka-Suzuki ◽  
Teruhiko Suzuki ◽  
Elena M. Pugacheva ◽  
Alexander A. Vostrov ◽  
Herbert C. Morse ◽  
...  
Keyword(s):  
Transcription Factor ◽  
Cancer Testis Antigen ◽  
Cancer Testis

scholarly journals Cancer-testis antigen MAGE-C1/ CT7 in multiple myeloma: literature review

2020 ◽  
Vol 15 (4) ◽  
pp. 29-37
Author(s):  
E. A. Makunina
Keyword(s):  
Multiple Myeloma ◽  
Germ Cells ◽  
Gene Families ◽  
Transformation Process ◽  
Cancer Testis Antigen ◽  
Hematological Diseases ◽  
Cancer Testis Antigens ◽  
Disease Prognosis ◽  
Tumor Transformation ◽  
Cancer Testis

Group of tumor-associated antigens, which is normally expressed in placental cells and testicular germ cells, is called cancer-testis antigens. To date, more than 40 gene families have been identified that encode cancer-testis antigens, and their expression has been studied in many types of malignant diseases. It is assumed that the expression of cancer-testis antigens can contribute to the development of the tumor transformation process, including hematological diseases. Of particular interest in the pathogenesis of multiple myeloma is the MAGE-C1/CT7 antigen, the expression of which is most often detected in this case. According to data published by various authors, the expression of MAGEC1 in multiple myeloma can be considered as an additional marker of a poor disease prognosis, represent the effectiveness of chemotherapy approaches, and, possibly, be an earlier predictor of relapse or progression.

Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1

2017 ◽  
Vol 61 ◽  
pp. 130-139 ◽  
Author(s):  
Kunio Iura ◽  
Akira Maekawa ◽  
Kenichi Kohashi ◽  
Takeaki Ishii ◽  
Hirofumi Bekki ◽  
...  
Keyword(s):  
Synovial Sarcoma ◽  
Antigen Expression ◽  
Cancer Testis Antigen ◽  
Cancer Testis
Sign in / Sign up

Export Citation Format

Share Document